Back to mobile site

Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens

June 2, 2026 4:30 AM EDT Send to a Friend
Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $45.00 price target on Ideaya Biosciences (NASDAQ: IDYA).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login